Cancer Follow-up
- During the surge leading up to and at the apogee of the COVID-19
incidence curve:
- Routine follow-ups in asymptomatic patients should be delayed,
including routine follow-up imaging.
- Radiologic surveillance for patients who are cancer-free but are at
risk for developing a cancer in the future should be delayed unless
symptoms or signs are concerning.
- Follow-up later in the COVID-19 pandemic when routine office visits
have resumed:
- Resume routine follow-ups in asymptomatic patients, including
routine follow-up imaging
- Since a third of asymptomatic COVID-19 patients have characteristic
chest CT findings, all patients that undergo CT of the chest or
total body PET/CT as part of their routine follow-imaging for their
cancer and who have radiographic evidence suggesting viral infection
should undergo SAR-CoV-2 testing.22